Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 2.98% | 310.47 | 0.0% | $5226.27m | |
| BNTX | BioNTech SE | 3.01% | 343.54 | 0.0% | $1578.93m | |
| NVAX | Novavax, Inc. | -0.83% | 160.63 | 78.2% | $850.44m | |
| AMGN | Amgen, Inc. | 0.48% | 202.14 | 1.4% | $596.10m | |
| GILD | Gilead Sciences, Inc. | -0.24% | 69.50 | 1.0% | $508.54m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.78% | 202.86 | 1.9% | $475.28m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.10% | 627.01 | 2.7% | $468.81m | |
| LGVN | Longeveron Inc. | 17.83% | 21.21 | 0.0% | $422.99m | |
| ILMN | Illumina, Inc. | -3.12% | 346.33 | 3.3% | $315.11m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -2.57% | 4.17 | 0.7% | $291.50m | |
| BIIB | Biogen, Inc. | -2.44% | 222.95 | 1.8% | $272.19m | |
| OCGN | Ocugen, Inc. | -9.21% | 5.73 | 0.0% | $192.28m | |
| INCY | Incyte Corp. | -1.46% | 65.66 | 2.4% | $153.95m | |
| EXAS | EXACT Sciences Corp. | -5.50% | 76.14 | 18.0% | $147.47m | |
| SGEN | Seagen Inc. | -4.95% | 150.81 | 5.8% | $143.89m |
Company Profile
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.